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treated with antibiotics were excluded. Analysis was restricted to those patient visita-
tion cared by physician specialty with general practice, family practice, and internal 
medicine. Multivariate logit regression analysis was performed to assess the relation-
ship between patient insurance status and the prescribing of broad-spectrum antibiot-
ics controlling for age, gender, race and ethnicity, physician specialty, and 
comorbidities. RESULTS: Of 851 adults patients care for ARTI, 38% were prescribed 
one or more broad-spectrum antibiotics. In multivariate regression analysis, compared 
to those with private insurance, those with Medicaid, a public insurance program for 
low-income Americans, was associated with lower likelihood of prescribing of broad-
spectrum antibiotics (adjusted odds ratio (OR) 0.496, p = 0.003), so were those 
without health insurance (adjusted OR 0.499, p = 0.028), and those with Medicare, 
a public insurance program for the elderly or disabled adults (adjusted OR 0.666, p 
= 0.091). CONCLUSIONS: In the case of ARTI, those with private insurance were 
substantially more likely to be prescribed with broad-spectrum antibiotics, where the 
society may be better off if such overuse of antibiotics could be reduced.
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OBJECTIVES: Increasing antibiotics costs and resistance led to establishment of 
educational project S-MedDial under guarantee of the General Health Insurance Fund 
and related professional associations. The project evaluates prescription habits in 
respiratory infections, monitors antibiotics resistance and provides individual feedback 
to pediatricians. Introduction of new indexes and summary quality bar from selected 
eight indexes has enhanced comparison among physicians and their willingness to 
improve. METHODS: In the last round of the project the antibiotic prescription was 
analyzed for 97 doctors in 7 Slovak regions based on the retrospective claims data 
from September 2007 to March 2008 and compared with previous season data. 
Individual feedback was provided to practitioners during regional meetings together 
with expert presentations and educative leaﬂets. RESULTS: Every second child with 
respiratory infection was treated with antibiotics. The most frequent drugs in DDD 
were macrolides (22.6%), followed by beta-lactamase sensitive penicillins (19.5%) 
and cephalosphorines (18.4%). Best pediatricians (20% of the group) were signiﬁ-
cantly different compared to the rest in majority of the quality bar indexes: less 
patients treated with ATB (31% vs. 51%); lower proportion of ATB in treatment (in 
EUR: 51% vs. 73%, in DDD: 28% vs. 51%); lower ATB costs per patient (−15%); 
lower aminopenicillins usage in acute tonsillopharyngitis (6% vs. 16%); lower ATB 
ratio in acute sinusitis (43% vs. 57%); however high ratio of macrolides was the 
problem across all groups. Higher prescription quality and lower ATB costs correlated 
together. There was signiﬁcant decrease of ATB costs induced by one pediatrician 
during six years of the project (−50%). CONCLUSIONS: S-MedDial project repre-
sents an option for increase of antibiotics prescription quality using the prescribing 
practitioners’ education. Analysis of prescription habits is suitable not only for cost 
control but also for antibiotics prescription implications on resistance trends. Long-
term integrated educational program leads to prescription habits change and better 
quality of care.
PRS46
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OBJECTIVES: Many guidelines were released during the past decade which tried to 
explain appropriate drug use for patients diagnosed with COPD. Medication use in 
COPD is also associated with issues related to adherence and side effects. The purpose 
of this study was to determine trends in prescription of COPD drugs in ambulatory 
setting and assess the rate of change in different drug classes. METHODS: We com-
bined National Ambulatory Care Settings (NAMCS) and National Hospital Ambula-
tory Care Settings (NHAMCS) data from year 1996 to 2005. For trend analysis, data 
were stratiﬁed in 2-year periods. All adult visits with only primary diagnosis of COPD 
(ICD-9-CM: 491, 492, 496) were included in analysis and drug categories were identi-
ﬁed using National Drug Codes. Descriptive analysis was carried out to determine 
patterns in drug prescription across years and four separate multivariate logistic 
models, dependent variable being drug class and independent variable being year, were 
constructed to identify rate of change in drug use across years while controlling for 
age, race, sex and smoking status. RESULTS: From 1996–97 to 2004–05, total COPD 
visits have been increased from 0.59% to 0.77%; Prescription of anticholinergics and 
inhaled corticosteroids increased (17.47% to 33.48% and 12.63% to 35.19% respec-
tively), whereas beta-agonist had no upward trend (29.46% to 29.53%). In year 
1996–97, beta-agonist was the highly prescribed drug (29.46%) whereas in 2004–05, 
anticholinergics (33.48%) and inhaled corticosteroids (35.19%) were the top pre-
scribed medications. From year 1996 to 2005, prescription of anticholinergics (OR-
1.088; CI-1.029–1.151) and inhaled corticosteroids (OR-1.132; CI-1.065–1.203) 
increased, beta agonist use has decreased (OR-0.916; CI-0.866–0.969) whereas there 
was no change for systemic corticosteroids (OR-1.034; CI-0.979–1.092). CONCLU-
SIONS: Overall drug utilization for COPD is increasing steadily. Use of bronchodila-
tors is increasing which is in accordance with Global initiative for Chronic Obstructive 
Lung Disease (GOLD) guidelines. Corticosteroid use which is increasing should be 
based on risk to beneﬁt ratio.
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OBJECTIVES: To compare three common risk adjustment models when estimating 
health care costs. METHODS: Using data from U.S. claims databases, the effect of 
treatment on total health care expenditures among asthma patients was estimated. 
Reimbursement amounts were dollars paid by the health plan to the provider including 
patient co-payments and deductibles. Doctors’ prescribing patterns were used as an 
instrumental variable for treatment choice. Propensity score matching was employed 
using the nearest neighbor matching algorithm. Generalized linear model was used as 
an alternative risk adjustment technique. RESULTS: Patients treated with control 
medication were younger, more likely to live in the northeast and south of the United 
States and have a higher Charlson comorbidity score, Elixhauser score and chronic 
disease score relative to patients treated with reliever medication. The difference 
between one year health care costs for reliever and controller medication was $2,345 
by propensity score matching, $2,195 by generalized linear model, and $2,997 by 
instrumental variable approach. The difference was statistically signiﬁcant. CONCLU-
SIONS: After adjusting for patient clinical and demographic characteristics, controller 
medication was less costly than reliever medication. The choice of risk adjustment was 
important. The technique that controlled for both observed and unobserved biases 
(instrumental variable technique) provided a difference of almost 30% higher than 
the other techniques.
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OBJECTIVES In most outcome studies, comorbidity inﬂuence is modelled as constant 
with inherent assumptions that the duration of the condition does not inﬂuence 
prognosis and the effect persists. We challenge these assumptions as we demonstrate 
the time-dependent nature of the inﬂuence of certain comorbidities on patient survival. 
METHODS A retrospective cohort of 23,881 patients aged 50+ in the UK-GPRD at 
time of incident COPD diagnosis between 1990 and 1998 provided an appropriate 
setting. Each death patient was matched to as many survivors from the same practice 
as possible, of same age, sex and COPD duration. Some 18 binary comorbidities 
measured at the time of death were analysed in relation to mortality. Using conditional 
logistic regression model, we estimated hazard ratio (HR) for each comorbidity, 
adjusted for key baseline characteristics in two different models: In model A, we 
treated comorbidities as constant variables, whilst in B, we stratiﬁed each into two 
time-dependent categorical variables. We retained interactions between comorbidities 
which were signiﬁcant. RESULTS Some 2938 dead patients were matched to 5792 
survivors. We found evidence of time-dependent effects on risk for all but peripheral 
vascular disease and diabetes. Only in model B did we ﬁnd evidence for peptic ulcer, 
moderate/severe liver disease and hemiplagia/paraplagia. The liver disease effect was 
signiﬁcant only in those diagnosed within a year of death (HR > 15; p = 0.0162), 
where as the hemiplagia/paraplagia effect was found only in those diagnosed over a 
year ago (HR > 1.6; p = 0.0163). CONCLUSIONS To adequately adjust for comorbid-
ity inﬂuence in outcome studies, we recommend stratiﬁcation of each comorbidity on 
the basis of its duration (at start of follow-up for a cohort, or at time of outcome for 
a case-control study) to test for possible time-dependent effect. Adopting such 
approach as part of the exploratory analysis may improve the model and lead to more 
accurate estimations
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OBJECTIVES: Demonstrate the differences in results from the use of two different 
methods for covariate adjustment when calculating differences in outcomes between 
groups. METHODS: The 2006 Nationwide Inpatient Sample hospital database was 
analyzed to estimate the clinical and economic impact to U.S. hospitals of air leaks 
during post-operative pulmonary surgery. For all stays with pulmonary surgery, length 
of stay (LOS), total charges, and in-hospital mortality rates were compared between 
stays including an air leak vs. stays without an air leak, while using two different 
methods to adjust for covariates: 1) multivariate regression analysis (ordinary least 
square regression for LOS and total charges, and logistic regression for in-hospital 
mortality) while controlling for age, gender, and hospital region; 2) 1:1 matched case-
